Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Aditya K. Gupta & Catherine Studholme. (2016) How do we measure efficacy of therapy in onychomycosis: Patient, physician, and regulatory perspectives. Journal of Dermatological Treatment 27:6, pages 498-504.
Read now
Read now
Shari R Lipner & Richard K Scher. (2015) Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail. Expert Review of Clinical Pharmacology 8:6, pages 719-731.
Read now
Read now
Manish V. Saner, Abhijeet D. Kulkarni & Chandrakantsing V. Pardeshi. (2014) Insights into drug delivery across the nail plate barrier. Journal of Drug Targeting 22:9, pages 769-789.
Read now
Read now
H. N. Shivakumar, Abhishek Juluri, B. G. Desai & S. Narasimha Murthy. (2012) Ungual and Transungual drug delivery. Drug Development and Industrial Pharmacy 38:8, pages 901-911.
Read now
Read now
Jason G Newland & Susan M Abdel-Rahman. (2009) Update on terbinafine with a focus on dermatophytoses. Clinical, Cosmetic and Investigational Dermatology 2, pages 49-63.
Read now
Read now
H Degreef, J Heeres & M Borgers PhD. (2006) Antifungal azoles for skin disorders. Expert Opinion on Therapeutic Patents 16:9, pages 1235-1253.
Read now
Read now
Articles from other publishers (46)
Khushbu Mahajan, Chander Grover, Vineet Relhan, Sushil Tahiliani, Archana Singal, MManjunath Shenoy & Deepak Jakhar. (2023) Nail Society of India (NSI) recommendations for pharmacologic therapy of onychomycosis. Indian Dermatology Online Journal 14:3, pages 330.
Crossref
Crossref
Vinam Puri, Anna Froelich, Parinbhai Shah, Shernelle Pringle, Kevin Chen & Bozena Michniak-Kohn. (2022) Quality by Design Guided Development of Polymeric Nanospheres of Terbinafine Hydrochloride for Topical Treatment of Onychomycosis Using a Nano-Gel Formulation. Pharmaceutics 14:10, pages 2170.
Crossref
Crossref
S. Hamane, B. Joannard, M. Benderdouche, A. Mingui, S. Dellière, A. Alanio, A. Petit, G. Gabison, M. Bagot & S. Bretagne. (2022) Emergence de dermatophytoses résistant à la terbinafine : futurs défis. Annales de Dermatologie et de Vénéréologie - FMC 2:5, pages 376-383.
Crossref
Crossref
Julianne M. Falotico, Rebecca Lapides & Shari R. Lipner. (2022) Combination Therapy Should Be Reserved as Second-Line Treatment of Onychomycosis: A Systematic Review of Onychomycosis Clinical Trials. Journal of Fungi 8:3, pages 279.
Crossref
Crossref
T. Razavyoon, S.J. Hashemi, S. Ansari, P. Mansouri, R. Daie-Ghazvini, S. Khodavaisy, Z. Rafat, H. Kamali Sarvestani, L. Hosseinpour, P. Afshar, F. Hashemi & F. safaie. (2022) Neoscytalidium dimidiatum as onychomycosis causative agent in an Iranian patient: a case report and literature review. New Microbes and New Infections 45, pages 100952.
Crossref
Crossref
Dieter Reinel. (2021) Non‐dermatophyte fungi in onychomycosis—Epidemiology and consequences for clinical practice. Mycoses 64:7, pages 694-700.
Crossref
Crossref
Keita Sugiura, Akane Masumoto, Haruki Tachibana & Yoshiyuki Tatsumi. (2021) In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale. Journal of Fungi 7:3, pages 208.
Crossref
Crossref
Aditya K. Gupta, Maanasa Venkataraman & Emma M. Quinlan. 2021. Dermatophytes and Dermatophytoses. Dermatophytes and Dermatophytoses
433
471
.
Maria Teresa García-Romero, Gabriela Sánchez-Cardenas, Silvia Angélica Carmona-Cruz & Mónica Fernández-Sánchez. (2020) Skin Fungal Infections in Children: Diagnostic Challenges. Current Fungal Infection Reports 14:4, pages 329-347.
Crossref
Crossref
Enrique Alberdi & Clara Gómez. (2020) Methylene blue vs methyl aminolevulinate photodynamic therapy in combination with oral terbinafine in the treatment of severe dermatophytic toenail onychomycosis: Short‐ and long‐term effects. Mycoses 63:8, pages 859-868.
Crossref
Crossref
Tracey C. Vlahovic. 2020. Evidence-Based Podiatry. Evidence-Based Podiatry
11
20
.
Kelvin Yeung, Vinzent Kevin Ortner, Torben Martinussen, Uwe Paasch & Merete Haedersdal. (2019) Efficacy of laser treatment for onychomycotic nails: a systematic review and meta-analysis of prospective clinical trials. Lasers in Medical Science 34:8, pages 1513-1525.
Crossref
Crossref
Jessica Houang, Gabriel Perrone, Christian Pedrinazzi, Leonardo Longo, Damia Mawad, Philip Boughton, Andrew Ruys & Antonio Lauto. (2019) A genome-wide screen for tolerance to rose bengal photodynamic therapy and its use in onychomycosis treatment. A genome-wide screen for tolerance to rose bengal photodynamic therapy and its use in onychomycosis treatment.
Nur Khamidah & Evy Ervianti. (2018) COMBINATION ANTIFUNGAL THERAPY FOR ONYCHOMYCOSIS. Indonesian Journal of Tropical and Infectious Disease 7:1, pages 15.
Crossref
Crossref
Jessica Houang, Gabriel Perrone, Damia Mawad, Philip C. Boughton, Andrew J. Ruys & Antonio Lauto. (2018) Light treatments of nail fungal infections. Journal of Biophotonics 11:3.
Crossref
Crossref
Avner Shemer, Aditya K. Gupta, Meir Babaev, Aviv Barzilai, Renata Farhi & C. Ralph Daniel III. (2018) A Retrospective Study Comparing K101 Nail Solution as a Monotherapy and in Combination with Oral Terbinafine or Itraconazole for the Treatment of Toenail Onychomycosis. Skin Appendage Disorders 4:3, pages 166-170.
Crossref
Crossref
Bárður Sigurgeirsson. 2018. Scher and Daniel's Nails. Scher and Daniel's Nails
185
214
.
Martha Patricia Sol?s-Arias & Maria Teresa Garc?a-Romero. (2017) Onychomycosis in children. A review. International Journal of Dermatology 56:2, pages 123-130.
Crossref
Crossref
Aditya K. Gupta, Kelly A. Foley & Sarah G. Versteeg. (2016) New Antifungal Agents and New Formulations Against Dermatophytes. Mycopathologia 182:1-2, pages 127-141.
Crossref
Crossref
Aditya K. Gupta, Maria Cernea & Kelly A. Foley. (2016) Improving Cure Rates in Onychomycosis. Journal of Cutaneous Medicine and Surgery 20:6, pages 517-531.
Crossref
Crossref
Tracey C. Vlahovic. (2016) Onychomycosis. Clinics in Podiatric Medicine and Surgery 33:3, pages 305-318.
Crossref
Crossref
Tracey C. VlahovicWarren S. JosephRichard K. ScherAntonella TostiJesse PlasenciaDavid M. PariserBryan C. Markinson. (2016) Diagnosis and Management of Onychomycosis. Journal of the American Podiatric Medical Association 106:2, pages 155-162.
Crossref
Crossref
Bárður Sigurgeirsson. 2016. Antibiotic and Antifungal Therapies in Dermatology. Antibiotic and Antifungal Therapies in Dermatology
203
289
.
T. Auvinen, R. Tiihonen, M. Soini, M. Wangel, A. Sipponen & J.J. Jokinen. (2015) Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial. British Journal of Dermatology 173:4, pages 940-948.
Crossref
Crossref
Aditya K. GuptaMaryse Paquet. (2015) Management of Onychomycosis in Canada in 2014. Journal of Cutaneous Medicine and Surgery 19:3, pages 260-273.
Crossref
Crossref
Stephanie Feldstein, Christine Totri & Sheila Fallon Friedlander. (2015) Antifungal therapy for onychomycosis in children. Clinics in Dermatology 33:3, pages 333-339.
Crossref
Crossref
A. Shemer, N. Sakka, R. Baran, R. Scher, B. Amichai, L. Norman, R. Farhi, R. Magun, A. Brazilai & R. Daniel. (2015) Clinical comparison and complete cure rates of terbinafine efficacy in affected onychomycotic toenails. Journal of the European Academy of Dermatology and Venereology 29:3, pages 521-526.
Crossref
Crossref
M. Ameen, J.T. Lear, V. Madan, M.F. Mohd Mustapa, M. Richardson, J.R. Hughes, A. Sahota, M. Griffiths, A.J. McDonagh, S. Punjabi, D.A. Buckley, I. Nasr, V.J. Swale, C.E. Duarte Williamson, P.M. McHenry, N.J. Levell, T. Leslie, E. Mallon, K. Towers, R. Davis, C. Saunders, S.E. Haveron & L.S. Exton. (2014) British Association of Dermatologists' guidelines for the management of onychomycosis 2014. British Journal of Dermatology 171:5, pages 937-958.
Crossref
Crossref
Aditya K. Gupta, Elizabeth A. Cooper, Maryse Paquet & Fiona Simpson. 2014. Evidence-Based Dermatology. Evidence-Based Dermatology
349
363
.
Aditya K. Gupta & Maryse Paquet. (2013) Improved efficacy in onychomycosis therapy. Clinics in Dermatology 31:5, pages 555-563.
Crossref
Crossref
M. Machouart, P. Menir, R. Helenon, D. Quist & N. Desbois. (2013) Scytalidium and scytalidiosis: What's new in 2012?. Journal de Mycologie Médicale 23:1, pages 40-46.
Crossref
Crossref
Roderick J. Hay & Robert Baran. 2012. Baran & Dawber's Diseases of the Nails and their Management. Baran & Dawber's Diseases of the Nails and their Management
211
255
.
Lauren Van Duyn Graham & Boni E. Elewski. (2011) Recent updates in oral terbinafine: its use in onychomycosis and tinea capitis in the US. Mycoses 54:6, pages e679-e685.
Crossref
Crossref
S. J. Weir, L. Patton, K. Castle, L. Rajewski, J. Kasper & A. D. Schimmer. (2011) The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy. Journal of Clinical Pharmacy and Therapeutics 36:2, pages 128-134.
Crossref
Crossref
J. Thomas, G. A. Jacobson, C. K. Narkowicz, G. M. Peterson, H. Burnet & C. Sharpe. (2010) REVIEW ARTICLE: Toenail onychomycosis: an important global disease burden. Journal of Clinical Pharmacy and Therapeutics 35:5, pages 497-519.
Crossref
Crossref
Susan Keiler. 2009. Antifungal Therapy. Antifungal Therapy
258
277
.
Peter Mayser, Viviane Freund & Debby Budihardja. (2009) Toenail Onychomycosis in Diabetic Patients. American Journal of Clinical Dermatology 10:4, pages 211-220.
Crossref
Crossref
D. Scot Malay, Sang Yi, Pamela Borowsky, Michael S. Downey & Alan J. Mlodzienski. (2009) Efficacy of Debridement Alone Versus Debridement Combined with Topical Antifungal Nail Lacquer for the Treatment of Pedal Onychomycosis: A Randomized, Controlled Trial. The Journal of Foot and Ankle Surgery 48:3, pages 294-308.
Crossref
Crossref
Aditya K. GuptaMuhammad ZamanJagpal Singh. (2008) Diagnosis of Trichophyton rubrum from Onychomycotic Nail Samples Using Polymerase Chain Reaction and Calcofluor White Microscopy. Journal of the American Podiatric Medical Association 98:3, pages 224-228.
Crossref
Crossref
Chia-Hsuin Chang, Yinong Young-Xu, Tobias Kurth, John E. Orav & Arnold K. Chan. (2007) The Safety of Oral Antifungal Treatments for Superficial Dermatophytosis and Onychomycosis: A Meta-analysis. The American Journal of Medicine 120:9, pages 791-798.e3.
Crossref
Crossref
C. Seebacher, J. Brasch, D. Abeck, O. Cornely, I. Effendy, G. Ginter-Hanselmayer, N. Haake, G. Hamm, U.-Ch. Hipler, H. Hof, H. C. Korting, P. Mayser, M. Ruhnke, K.-H. Schlacke & H.-J. Tietz. (2007) Onychomycosis. Mycoses 50:4, pages 321-327.
Crossref
Crossref
M. J. Korstanje. (2007) Onychomycosen: wel of niet behandelen en zo ja, hoe?. Bijblijven 23:3, pages 25-32.
Crossref
Crossref
Daniel S Loo. (2007) Onychomycosis in the Elderly. Drugs & Aging 24:4, pages 293-302.
Crossref
Crossref
Claus Seebacher, Jochen Brasch, Dietrich Abeck, Oliver Cornely, Isaak Effendy, Gabriele Ginter-Hanselmayer, Norbert Haake, Gudrun Hamm, Uta-Christina Hipler, Herbert Hof, Hans Christian Korting, Peter Mayser, Markus Ruhnke, Kurt-Heiner Schlacke & Hans-Jörgen Tietz. (2007) Onychomycosis. JDDG 5:1, pages 61-66.
Crossref
Crossref
Justin J. Finch & Erin M. Warshaw. (2007) Toenail onychomycosis: current and future treatment options. Dermatologic Therapy 20:1, pages 31-46.
Crossref
Crossref
Jason A. Winston & Jami L. Miller. (2006) Treatment of Onychomycosis in Diabetic Patients. Clinical Diabetes 24:4, pages 160-166.
Crossref
Crossref